Product List


Description of Lenvanix 4

First new frontline treatment option for HCC approved in Japan Lenvatinib is amultikinase inhibitor that interrupts the pathways of VEGFR1,VEGFR2 and VEGFR3.It is used in the treatment of differentiated thyroid cancer (DTC),renal Cell Carcinoma and Hepatocellular Carcinoma (HCC)

Generic Brand Name Formulation & Strength Pack Size
Lenvatinib Lenvanix 4 Capsule ( 4 mg ) 30's Pot

Website Prescribing Information Order Now